Tatva Chintan Pharma Chem Limited is reinforcing its leadership core with the reappointment of three senior executives for a fresh three-year term as it gears up for its growth agenda. The board has approved the re-appointment of Chintan Nitinkumar Shah as Managing Director from February 1, 2027 to January 31, 2030, Ajaykumar Mansukhlal Patel as Whole-time Director for the same period, and Shekhar Rasiklal Somani as Whole-time Director for the same period, all subject to approval by the company’s members at the upcoming Annual General Meeting. The move underscores continuity at the top as the company pursues its strategic expansion plans.
The trio are established leaders within Tatva Chintan. Chintan Nitinkumar Shah, a founder-promoter who has been with the company since 1996, serves as the Managing Director. Ajaykumar Mansukhlal Patel, another founder-promoter, has likewise steered operations for decades as a Whole-time Director, and Shekhar Rasiklal Somani, also a founder-promoter, brings his long-standing experience as a Whole-time Director. Their profiles highlight a shared history of leadership, including roles within the group’s international subsidiaries — Tatva Chintan USA Inc. and Tatva Chintan Europe B.V. — reflecting the group’s global footprint.
This leadership refresh comes as Tatva Chintan advances a significant capacity expansion at its Dahej greenfield unit, with planned reactor capacity of 344 kilolitres and an estimated investment around Rs 200 crore. The project, designed to meet rising demand for specialty chemicals, will be financed through a blend of internal accruals and debt over roughly 21 months. In tandem with the capacity push, the Board has also approved a substantial increase in borrowing limits from Rs 300 crore to Rs 1,000 crore, subject to member approval at the AGM, signaling a deliberate alignment of governance with growth goals.
Taken together, the announcements reflect Tatva Chintan’s emphasis on stable leadership alongside ambitious capacity expansion, as the company positions itself to capture growing opportunities in the specialty chemicals space.